Definition & Epidemiology
Genetic condition characterized by an extra copy of chromosome 21 in every somatic cell.
Most common chromosomal anomaly diagnosed in the United States.
Leading global cause of intellectual disability.
Cytogenetic Variants
Trisomy 21 (Standard)
Each cell has three complete copies of chromosome 21.
Accounts for ext{≈}95\% of cases.
Translocation Down Syndrome
A segment of chromosome 21 is attached (translocated) to another chromosome (often 14 or 22).
Represents 3\% of diagnoses.
Mosaic Down Syndrome
Mixture of two cell lines: some cells have the typical two copies of chromosome 21, others have three.
Produces milder phenotype in ≈2\% of individuals.
Risk Factors & Screening
Incidence increases with advanced maternal age (≥35 yrs).
Routine prenatal screening for all pregnancies:
First & second-trimester maternal serum markers.
Fetal ultrasound for nuchal translucency & structural anomalies.
If screen is positive → diagnostic testing:
Chorionic villus sampling (CVS) at 10\text{–}14 wks gestation.
Amniocentesis ≥15 wks gestation.
Percutaneous umbilical blood sampling (PUBS) in selected scenarios.
Characteristic Physical Findings
Flattened nasal bridge, up-slanting almond-shaped palpebral fissures.
Single transverse palmar (simian) crease.
Short neck with excess skin folds.
Small pinnae; protruding tongue relative to oral cavity.
Common Comorbidities
Congenital heart defects (e.g., AV canal).
Obstructive sleep apnea.
Ophthalmologic & hearing disorders.
Gastrointestinal anomalies (duodenal atresia, Hirschsprung disease).
Hematologic: iron-deficiency anemia, leukemia (esp. ALL & AML-M7).
Endocrine: hypothyroidism.
Development & Learning
Mild–moderate intellectual disability; global developmental delays.
Sensory-processing challenges → delayed milestones.
Speech often delayed; non-verbal communication preferred early.
Nursing & Interdisciplinary Management
Early intervention within first month of life (PT, OT, ST).
Break ADLs into smaller steps; emphasize strengths.
Annual screening of:
Medical issues, nutrition, accident risk.
Financial & psychosocial needs of family.
School-age: IEPs, classroom aide to enhance social integration; include siblings in care plans.
Genetic counseling offered to all families (recurrence risk ≈1\% for trisomy; higher for translocation carriers).
Etiology & Genetics
Caused by mutation (CGG trinucleotide repeat expansion) of the fragile‐X messenger ribonucleoprotein gene (FMR1) on the X chromosome.
Most common inherited form of developmental/intellectual disability.
Inheritance Pattern
X-linked dominant with variable penetrance.
Females (carriers): 50\% chance of transmitting mutation to each child.
Males (full mutation): transmit mutated X to all daughters (obligate carriers), none to sons.
Genetic counseling recommended for suspected cases & carrier families.
Physical Manifestations (become prominent peri-/post-puberty)
Long, narrow face with prominent forehead & chin.
Large, protruding ears; macrocephaly.
Joint laxity; pes planus (flat feet).
Macro-orchidism (enlarged testes) in post-pubertal males.
Cognitive & Behavioral Features
Early childhood: language delays, sensory-processing disorders.
Social anxiety, shyness, poor eye contact.
Learning deficits ranging from mild difficulties to severe disability; females usually milder.
Common Comorbidities
Recurrent otitis media & sinusitis.
Visual refractive errors.
Mitral valve prolapse.
Seizure disorders.
Management
Individualized, multidisciplinary: speech, occupational, behavioral therapies.
School-based supports (IEP, assistive communication devices).
Ongoing monitoring for ENT issues, cardiac function, seizures.
Obligate nose breathing from birth until \approx 6 months → nasal swelling can rapidly compromise airway.
Chest wall nearly circular; weak intercostals → rapid fatigue.
Oral cavity: larger tongue, base directly contacts epiglottis.
Narrow nasal passages; short pharynx, enlarged adenoids/tonsils.
Larynx positioned anteriorly; epiglottis higher & more horizontal.
Trachea: shorter, narrower, less cartilaginous support.
Alveolar count: \approx 17\text{ million} at birth vs 600\text{ million} in adults.
Fewer developed paranasal sinuses; proportionally larger head & shorter neck.
Wheezing: high-pitched musical sound (mostly on expiration) → obstruction, asthma, viral bronchiolitis.
Rales (Crackles): popping sounds from fluid-filled alveoli (e.g., pneumonia, pulmonary edema).
Transmission: direct contact & respiratory droplets.
Pathophysiology: viral invasion → airway inflammation, mucosal edema, ↑ secretions.
Incubation: 1\text{–}3 days; symptomatic phase 4\text{–}10 days.
Upper Respiratory Infections (URIs)
Most frequent ARI category; highest incidence in children <5 yrs.
Predominantly viral; peak in winter/spring.
Pediatric anatomy predisposes to more severe manifestations.
Immature immune system → limited adaptive responses.
High exposure (daycare, school) & behavioral hand-to-mouth tendencies.
Viral shedding higher & longer vs adults → easier spread.
Observe rate, rhythm, effort; note retractions, nasal flaring, head bobbing.
Auscultate lungs for adventitious sounds.
Skin: color (pallor, cyanosis), temperature, moisture.
History: onset/duration, exposures, prior treatments, birth & prenatal details.
Mild: sneezing, cough, conjunctival drainage, fatigue, headache, low-grade fever.
Severe/Distress Indicators:
Tachypnea; increased WOB (retractions, grunting).
Unexpected lung sounds (wheezes, crackles).
Hypoxia (± hypercapnia): altered mental status.
Mild cases: clinical diagnosis; no labs.
Point-of-care tests: throat culture, rapid influenza A/B, RSV, COVID-19 swabs.
Imaging: chest X-ray if pneumonia or severe distress suspected.
CBC, blood gas for hospitalized or worsening patients.
Primarily supportive for viral URIs: hydration, antipyretics, nasal saline/suction.
Escalation for bacterial superinfection (e.g., antibiotics for streptococcal pharyngitis).
Hospitalization criteria: persistent hypoxia, apnea, dehydration, inability to maintain PO intake, worsening distress.
Child’s response influenced by developmental stage, prior medical experiences, family support.
Promote coping: age-appropriate explanations, parental presence, therapeutic play.
Ensure routine well-child visits and immunizations (e.g., influenza, COVID-19, pneumococcal, pertussis).
Parent education: hand hygiene, environmental cleaning (toy washing), limiting sick contacts.
Recognize early signs of distress; seek timely care.